Search All News
Pandemic Research Alliance headed by Dr. David Ho
Paxlovid is still a highly effective treatment for most people infected with SARS-CoV-2 and the drug prevents many hospitalizations and deaths from COVID.
New highly mutated BA.2.86 variant of COVID-19 is circulating in the US.
Lab data suggests the new COVID-19 booster shots should protect against a variant that concerns scientists
Source:Columbia University Irving Medical CenterAugust 15, 2023
Dr. David Ho speaks at Columbia University Vagelos College of Physicians and Surgeons White Coat Ceremony.
Source:The WeekAugust 13, 2023
A new Covid-19 variant, Eris has entered the scene, becoming the most prevalent strain in the U.S. However, it may not be as dangerous as the ones that came before.
Source:ANIAugust 10, 2023
The new variant is a spinoff of the XBB recombinant strain of the Omicron family.
Source:South China Morning PostJuly 22, 2023
Columbia University’s Professor David Ho told the Post that the Univ of Hong Kong (HKU) and Beijing’s Tsinghua University had given their blessing to the plan to build a “Pandemic Research Alliance”.
Source:Editorial by SCMP EditorialJuly 20, 2023
The initiative by Columbia Univ Prof D Ho and HKU Prof KY Yuen to create a global partnership to study emerging Inf Dis joined by China’s Tsinghua Univ and Doherty Inst/Univ of Melbourne in Australia.
Source:BioSpectrumJuly 18, 2023
Acclaimed US-based Columbia Univ virologist Prof D. Ho and HKU microbiologist Prof KY Yuen are teaming up to create a global alliance for conducting research in emerging infectious diseases.